Four different multivariate analyses were applied to evaluate whether ESRP1 or ESRP2 expression as well as our ESRP1/ESRP2 score is a statistically independent prognostic marker in all prostate cancers and the subset of ERG-negative and ERG-positive cancers (Table 3). The gene discussed is ERG; the disease is prostate carcinoma.